205 related articles for article (PubMed ID: 32436162)
1. Inhibition of neutrophil inflammatory mediator expression by azithromycin.
Gibson MP; Walters JD
Clin Oral Investig; 2020 Dec; 24(12):4493-4500. PubMed ID: 32436162
[TBL] [Abstract][Full Text] [Related]
2. Azithromycin enhances phagocytic killing of Aggregatibacter actinomycetemcomitans Y4 by human neutrophils.
Lai PC; Schibler MR; Walters JD
J Periodontol; 2015 Jan; 86(1):155-61. PubMed ID: 25186779
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulation Mediated by Azithromycin in Experimental Periapical Inflammation.
Andrada AC; Azuma MM; Furusho H; Hirai K; Xu S; White RR; Sasaki H
J Endod; 2020 Nov; 46(11):1648-1654. PubMed ID: 32763436
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Azithromycin and Amoxicillin Before Dental Implant Placement: An Exploratory Study of Bioavailability and Resolution of Postoperative Inflammation.
Escalante MG; Eubank TD; Leblebicioglu B; Walters JD
J Periodontol; 2015 Nov; 86(11):1190-200. PubMed ID: 26252749
[TBL] [Abstract][Full Text] [Related]
5. Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung.
Segal LN; Clemente JC; Wu BG; Wikoff WR; Gao Z; Li Y; Ko JP; Rom WN; Blaser MJ; Weiden MD
Thorax; 2017 Jan; 72(1):13-22. PubMed ID: 27486204
[TBL] [Abstract][Full Text] [Related]
6. Azithromycin may inhibit interleukin-8 through suppression of Rac1 and a nuclear factor-kappa B pathway in KB cells stimulated with lipopolysaccharide.
Matsumura Y; Mitani A; Suga T; Kamiya Y; Kikuchi T; Tanaka S; Aino M; Noguchi T
J Periodontol; 2011 Nov; 82(11):1623-31. PubMed ID: 21417583
[TBL] [Abstract][Full Text] [Related]
7. Effects of azithromycin, metronidazole, amoxicillin, and metronidazole plus amoxicillin on an in vitro polymicrobial subgingival biofilm model.
Soares GM; Teles F; Starr JR; Feres M; Patel M; Martin L; Teles R
Antimicrob Agents Chemother; 2015 May; 59(5):2791-8. PubMed ID: 25733510
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials.
Tomás I; Tomás M; Alvarez M; Velasco D; Potel C; Limeres J; Diz P
Oral Microbiol Immunol; 2007 Oct; 22(5):298-303. PubMed ID: 17803626
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants.
Aghai ZH; Kode A; Saslow JG; Nakhla T; Farhath S; Stahl GE; Eydelman R; Strande L; Leone P; Rahman I
Pediatr Res; 2007 Oct; 62(4):483-8. PubMed ID: 17667842
[TBL] [Abstract][Full Text] [Related]
10. Relative effectiveness of azithromycin in killing intracellular Porphyromonas gingivalis.
Lai PC; Walters JD
Clin Exp Dent Res; 2016 Jun; 2(1):35-43. PubMed ID: 29744147
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
12. A combination of irsogladine maleate and azithromycin exhibits addictive protective effects in LPS-induced human gingival epithelial cells.
Feng X; Liu J
Pharmazie; 2017 Feb; 72(2):91-94. PubMed ID: 29441859
[TBL] [Abstract][Full Text] [Related]
13. Occurrence and ecological risk assessment of antibiotic residues in urban wastewater discharged into the coastal environment of the Persian Gulf (the case of Bandar Abbas).
Daliri M; Martinez-Morcillo S; Sharifinia M; Javdan G; Keshavarzifard M
Environ Monit Assess; 2022 Oct; 194(12):905. PubMed ID: 36253567
[TBL] [Abstract][Full Text] [Related]
14. Azithromycin in viral infections.
Oliver ME; Hinks TSC
Rev Med Virol; 2021 Mar; 31(2):e2163. PubMed ID: 32969125
[TBL] [Abstract][Full Text] [Related]
15. Macrolide antibiotics directly reduce active oxygen generation by neutrophils in human peripheral blood.
Sugihara E; Koyanagi T; Niizeki T; Hirota N; Nagafuchi M; Yamada K; Kido Y; Ono N; Rikimaru T; Aizawa H
Kurume Med J; 2003; 50(1-2):9-15. PubMed ID: 12971257
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Azithromycin in a Mouse Pneumonia Model against Hospital-Acquired Methicillin-Resistant Staphylococcus aureus.
Yamashita Y; Nagaoka K; Kimura H; Suzuki M; Konno S; Fukumoto T; Akizawa K; Kaku N; Morinaga Y; Yanagihara K
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235625
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin Clears
Borkner L; Misiak A; Wilk MM; Mills KHG
Front Immunol; 2018; 9():1764. PubMed ID: 30105030
[TBL] [Abstract][Full Text] [Related]
18. Safety, efficacy, and analysis of key parameters after prophylactic administration of a sustained-release formulation of azithromycin in lung cancer surgery.
Taniguchi D; Watanabe H; Morinaga Y; Sasaki D; Matsuda J; Sato S; Kaku N; Miyazaki T; Matsumoto K; Tsuchiya T; Sakaeda T; Yanagihara K; Nagayasu T
Ann Palliat Med; 2021 May; 10(5):5098-5107. PubMed ID: 33894712
[TBL] [Abstract][Full Text] [Related]
19. An ex-vivo pharmacodynamic study comparing bactericidal activity of amoxicillin/sulbactam, azithromycin, doxycycline and levofloxacin against Streptococcus pneumoniae.
Bantar C; Nicola F; Arenoso H; Soutric J; Caruso N; Fernández Canigia L
J Chemother; 2004 Jun; 16(3):248-54. PubMed ID: 15330320
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin attenuates pulmonary inflammation and emphysema in smoking-induced COPD model in rats.
Wan YF; Huang ZH; Jing K; Li J; Wang Y; Xu CQ; Chen JH; Zheng YL
Respir Care; 2015 Jan; 60(1):128-34. PubMed ID: 25249648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]